Cisplatin in Cancer Therapy: Optimization of Treatment Regimens and Toxicity Protection

This publication has 16 references indexed in Scilit:

• Hypomagnesemia and Renal Magnesium Wasting in Patients Receiving Cisplatin
  Annals of Internal Medicine, 1979
• Enhanced inhibition of both cellular protein synthesis and malate dehydrogenase by aged aquoplatinum(II) complexes
  Chemico-Biological Interactions, 1979
• Clinical pharmacological and toxicological studies of Cis-diamminedichloroplatinum (II) by continuous intravenous infusion
  Biochimie, 1978
• 24-Hour infusion of cis-platinum in head and neck cancers
  Cancer, 1978
• Safe, rapid administration schedule for cis-platinum—mannitol
  Medical and Pediatric Oncology, 1978
• ALLERGIC REACTIONS TO CIS PLATINUM
  The Lancet, 1976
• Diaminodichloroplatinum: A phase I study showing responses in testicular and other tumors
  Cancer, 1974
• cis-Platinum (II) Diamminedichloride
  Published by Springer Nature ,1974
• Cis-Dichlorodiammineplatinum [II]: Inhibition of Nucleic Acid Synthesis in Lymphocytes Stimulated with Phytohemagglutinin
  Experimental Biology and Medicine, 1971
• Inhibitory effects of anti‐tumor platinum compounds on DNA, RNA and protein syntheses in mammalian cells in vitro
  International Journal of Cancer, 1970